1 Theres also no lot tracking, no requirement to report adverse events, and no one collecting safety data, so if users have reactions, you may not hear about it
This article stays tightly focused on the weight-loss question: what BPC-157 is, what evidence exists, what could plausibly influence body composition indirectly, why some people report the opposite outcome, and the safety/regulatory issues you should understand before taking claims at face value
10.1155/2020/2305784 36 HoffmannK.NagelA
The rate of weight loss was maintained throughout the treatment period, an encouraging trend for expectations of longer-term dosing. So what we have is a peptide that can effectively break down visceral adipose tissue (VAT) and reduce the rate at which fatty foods are converted into body fat
"FOXO4-D-Retro-Inverso targets extracellular matrix production in fibroblasts and ameliorates bleomycin-induced pulmonary fibrosis in mice"